Interestingly, while anti-PD-1 consistently exhibited efficacy, the synergistic effect of the combination therapy was abolished in Trp53-knockout mice bearing Trp53mut MC38 tumor (Fig. 5). The gene discussed is TP53; the disease is neoplasm.